Michael J. Capaldi

The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK.

The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members.

Oxford Innovation Ltd. operates business and office centers and provides consultancy and project management services. It offers office space and depending on the centre, workshop and laboratory space. The company was founded in 1987 and is headquartered in Oxford, the United Kingdom.

NDSL Group Ltd. provides battery monitoring solutions. Its main business is the supply of mission critical grade equipment that will identify potential UPS battery failure to fortune 100 companies, government agencies, and other organizations around the world. The company was founded in 1986 and is headquartered in Milton Keynes, the United Kingdom.

Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom.

SunTech Medical Group Ltd. engages in the manufacture and sale of blood pressure monitoring equipment. The company was founded on July 21, 2000 and is headquartered in Amersham, the United Kingdom.

Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom.